Cargando…

Drug-coated balloon in superficial femoral artery in-stent restenosis

The femoropopliteal artery is one of the commonest sites of involvement in peripheral artery disease (PAD) leading to intermittent claudication and/or critical limb ischemia. Endovascular therapy for superficial femoral artery (SFA) disease has been recognized as a safe and efficient therapy and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerardi, Donato, Alfani, Arturo, Tesorio, Tullio, Cioppa, Angelo, Esposito, Giovanni, Stabile, Eugenio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939540/ https://www.ncbi.nlm.nih.gov/pubmed/29743899 http://dx.doi.org/10.5114/aic.2018.74350

Ejemplares similares

Directional Atherectomy for Treating In-Stent Restenosis of the Superficial Femoral Artery
por: Cho, Sungsin, et al.
Publicado: (2020)

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
por: Miura, Takashi, et al.
Publicado: (2022)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

In-stent restenosis of superficial femoral artery: use all arrows in the quiver
por: Vadalà, Giuseppe, et al.
Publicado: (2022)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

The relationship between neutrophil–lymphocyte ratio and in-stent restenosis in superficial femoral artery
por: Yang, Yaobo, et al.
Publicado: (2020)

Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis
por: Elwany, Mostafa, et al.
Publicado: (2018)

Preprocedural Mean Platelet Volume Level Is a Predictor of In-Stent Restenosis of the Superficial Femoral Artery Stents in Follow-Up
por: Karauzum, Kurtulus, et al.
Publicado: (2018)

In-Stent Restenosis Progression in Human Superficial Femoral Arteries: Dynamics of Lumen Remodeling and Impact of Local Hemodynamics
por: Colombo, Monika, et al.
Publicado: (2021)

Intensive exercise therapy for restenosis after superficial femoral artery stenting: the REASON randomized clinical trial
por: Kato, Tamon, et al.
Publicado: (2022)

Open-Label Multicenter Registry on the Outcomes of In-Stent Restenosis Treated by Balloon Angioplasty with Optical Frequency Domain Imaging in the Superficial Femoral Artery (ISLAND-SFA Study)
por: Yanaka, Kenichi, et al.
Publicado: (2020)

Twisting of the Ranger drug‐coated balloon for treating superficial femoral artery disease
por: Kim, Su Hong, et al.
Publicado: (2022)

A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume
por: Yang, Yao Bo, et al.
Publicado: (2020)

The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2016)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment
por: Boc, Vinko, et al.
Publicado: (2023)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

3D modelling of drug-coated balloons for the treatment of calcified superficial femoral arteries
por: Colombo, Monika, et al.
Publicado: (2021)

Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2017)

Carotid Artery Stenting Using Five-French Distal Radial Vascular Access
por: Di Gioia, Giuseppe, et al.
Publicado: (2023)

Superficial Femoral Artery Pseudoaneurysm and Arterial Wall Destruction After Drug-Coated Balloon Treatment
por: Golouh, Valentin, et al.
Publicado: (2020)

Superficial femoral artery stent extrusion
por: Voruganti, Nihal, et al.
Publicado: (2021)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
por: Navarese, Eliano Pio, et al.
Publicado: (2012)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Prognostic value of post-procedural μQFR for drug-coated balloons in the treatment of in-stent restenosis
por: Liu, Lili, et al.
Publicado: (2023)

Two Years Efficacy of Paclitaxel-Coated Balloon Dilation for In-Stent Renal Artery Restenosis Due to Takayasu Arteritis
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
por: Montelione, Nunzio, et al.
Publicado: (2022)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Stent fractures after superficial femoral artery stenting
por: Park, Jae Young, et al.
Publicado: (2012)

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial
por: Jun, Eun Jung, et al.
Publicado: (2022)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
por: Zhang, Dai-Min, et al.
Publicado: (2020)

Multimodal Images of Crushed Superficial Femoral Artery Calcified Occlusion Treated by Paclitaxel-Coated Balloon Angioplasty
por: Yamamoto, Hiroyuki, et al.
Publicado: (2022)

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
por: Nijhoff, Freek, et al.
Publicado: (2015)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
por: Peng, Nina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sgictgkk34uj5n1vroeeq539k6